Phibro Animal Health | 应收帐款人

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 207.39M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

2.13

USD 26M

USD 30.48M

1.92K

EPS每股收益

USD 0.08

股本和储备

USD 332.36M

USD 101.87M

债务利息支出

USD 8.76M

USD 0.08

USD 603.6M

USD 2.09B

USD 3.19M

USD 332.36M

USD 25.53M

普通股股本

USD 4K

48.92

USD 4.84M

USD 309.26M

销售和管理费用

USD 76.34M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 160.78M

	应收帐款人	更改		日
Align Technology	USD 1.1B		2.38M	2025-12
ANI Pharmaceuticals	USD 252.62M		26.96M	2025-09
Assertio Holdings	USD 39.91M		2.7M	2024-06
Aurora Cannabis	CAD 46.73M		7.59M	2025-09
Bristol-Myers Squibb	USD 14.62B		485M	2025-09
Canopy Growth	CAD 26.86M		23.17M	2025-09
Corcept Therapeutics	USD 69.63M		5.06M	2025-09
Eli Lilly	USD 19.46B		2.25B	2025-09
Henry Schein	USD 1.74B		98M	2025-09
Idexx Laboratories	USD 552.38M		14.5M	2025-12
Knight Therapeutics	CAD 103M		8.1M	2024-09
Merck	USD 12.12B		596M	2025-09
Nektar Therapeutics	USD 0		2.9M	2024-09
Pacira	USD 115.27M		901K	2025-09
Phibro Animal Health	USD 160.78M		8.67M	2024-09
Prestige Brands	USD 190.46M		8.54M	2025-12
Supernus Pharmaceuticals	USD 171.25M		30.42M	2025-09
Zoetis	USD 1.54B		1000K	2025-09

Phibro Animal Health 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.